WEST PHARMACEUTICAL SERVICES, INC. $150,000,000 Principal Amount 4.00% Convertible Junior Subordinated Debentures due 2047 UNDERWRITING AGREEMENTUnderwriting Agreement • March 14th, 2007 • West Pharmaceutical Services Inc • Fabricated rubber products, nec • New York
This Lock-Up Agreement is being delivered to you in connection with the proposed Underwriting Agreement (the “Underwriting Agreement”) to be entered into by West Pharmaceutical Services, Inc., a Pennsylvania corporation (the “Company”), and you and the other Underwriters named in Schedule A to the Underwriting Agreement, with respect to the public offering (the “Offering”) of Convertible Junior Subordinated Debentures (the “Debentures”) of the Company. Capitalized terms used herein without definition shall have the respective meanings ascribed to them in the Underwriting Agreement.
FIRST SUPPLEMENTAL INDENTURE BETWEEN WEST PHARMACEUTICAL SERVICES, INC. AND U.S. BANK NATIONAL ASSOCIATION DATED AS OF MARCH 14, 2007 4.00% CONVERTIBLE JUNIOR SUBORDINATED DEBENTURES DUE 2047First Supplemental Indenture • March 14th, 2007 • West Pharmaceutical Services Inc • Fabricated rubber products, nec • New York
FIRST SUPPLEMENTAL INDENTURE, dated as of March 14, 2007 (this “First Supplemental Indenture”), between WEST PHARMACEUTICAL SERVICES, INC., a Delaware corporation (the “Company”) and U.S. BANK NATIONAL ASSOCIATION, as Trustee (the “Trustee”), supplementing the Subordinated Indenture, dated as of March 14, 2007, between the Company and the Trustee (the “Base Indenture,” together with this First Supplemental Indenture, the “Indenture”).
